Dean Y Li insider trades

Open-market stock purchases and sales by Dean Y Li, Director at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 26, 2021.

Recent trades

DateStockTradeValue
Jun 17, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
May 5, 2026MRK Merck & Co, IncBought (not open market)—
May 5, 2026MRK Merck & Co, IncBought (not open market)—
Apr 29, 2026MRK Merck & Co, IncSold (not open market)$256K
Apr 29, 2026MRK Merck & Co, IncBought (not open market)—
Apr 1, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Feb 10, 2026MRK Merck & Co, IncSold$1.2M
Feb 4, 2026MRK Merck & Co, IncSold$1.8M
Feb 4, 2026MRK Merck & Co, IncBought (not open market)—
Jan 26, 2026MRK Merck & Co, IncBought (not open market)$2.2M
Jan 2, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—

Companies traded

  • RXRX Recursion Pharmaceuticals, Inc: 8 sales, last Jun 17, 2026
  • MRK Merck & Co, Inc: 3 sales, last May 5, 2026

Get free alerts when Dean Y Li files a new trade →